Galina Perel, PharmD, RPh, currently serves as Associate Director for Solid Tumors in the MSL team at Jazz Pharmaceuticals, a position held since May 2020. Prior experience includes roles as Senior Oncology Medical Science Liaison at Teva Pharmaceuticals, where responsibilities involved providing medical support in Movement Disorders and Psychiatry, and engaging key opinion leaders. At Novartis Oncology, Perel contributed to managing multiple global oncology projects as a Post-doctoral Fellow, executing medical strategy, and supporting significant product launches. Perel's background includes adjunct faculty positions and pharmacy externships in various healthcare settings. Galina Perel earned a Doctor of Pharmacy degree from St. John's University.